{"type":"rich","version":"1.0","title":"The evidence base for GLP-1 receptor agonist safety is reassuring over 2–3 year horizons but genuine","provider_name":"Mesh","provider_url":"https://www.isonomia.app","cache_age":3600,"html":"<iframe src=\"https://www.isonomia.app/embed/argument/Fm6T1Nm8\" width=\"600\" height=\"400\" frameborder=\"0\" style=\"border: 1px solid #e5e7eb; border-radius: 8px;\" title=\"The evidence base for GLP-1 receptor agonist safety is reassuring over 2–3 year horizons but genuine\" loading=\"lazy\"></iframe>","width":600,"height":400,"thumbnail_url":"https://www.isonomia.app/api/og/argument/Fm6T1Nm8","thumbnail_width":1200,"thumbnail_height":630}